Evaluation of thrombotic and/or bleeding risks associated with anticoagulotherapy.

Related content

• Activities

• XXV Congress of the International Society on Thrombosis and Haemostasis

  Activity: Participating in or organising an event types › Participation in conference

• Educational I - Should we measure DOACs?

  Activity: Talk or presentation types › Oral presentation

• Interference of DOACs in coagulation tests

  Activity: Talk or presentation types › Oral presentation

• Laboratory testing in patients treated with DOACs: a practical guide for clinicians and lab scientists

  Activity: Talk or presentation types › Invited talk

• Clinical Debate: There is a need for DOAC testing in emergency situations and elective preoperative setting - YES

  Activity: Talk or presentation types › Oral presentation

• Laboratory testing in patients treated with DOACs: a practical guide for clinicians

  Activity: Talk or presentation types › Oral presentation

• Research output

• Impact of edoxaban on a large panel of routine and more specific coagulation assays

  Research output: Contribution to conference › Poster › peer-review

• Comparison of Biophen DiXaI®, Prothrombin Time With a Reference HPLC-MS/MS Method to Monitor Patients Receiving Rivaroxaban

  Research output: Contribution to conference › Poster › peer-review

• Measurement of non-VKA oral anticoagulants versus classic ones: The appropriate use of hemostasis assays

  Research output: Contribution to journal › Review article › peer-review

• Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate

  Research output: Contribution to journal › Article › peer-review

• 2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

  Research output: Contribution to journal › Article › peer-review

• Rivaroxaban (Xarelto®): Guide de la pratique officinale

  Research output: Contribution to journal › Review article › peer-review

• Edoxaban: Impact on routine and specific coagulation assays. A practical laboratory guide

  Research output: Contribution to journal › Article › peer-review

• Comparison of Biophen DiXaI®, Prothrombin Time With a Reference HPLC-MS/MS Method to Monitor Patients Receiving Rivaroxaban

  Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution

• Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting

  Research output: Contribution to journal › Review article › peer-review

• Effect of dabigatran etexilate on the risk of myocardial infarction and other cardiac events: A systematic review and updated dose-response meta-analysis of randomized controlled trials

  Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution

• Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate

  Research output: Contribution to journal › Article › peer-review

• Preventive strategies against bleeding due to nonvitamin K antagonist oral anticoagulants

  Research output: Contribution to journal › Review article › peer-review

• Real-world variability in dabigatran levels in patients with atrial fibrillation: comment

  Research output: Contribution to journal › Letter › peer-review

• Target-specific oral anticoagulants - New approaches in the field of oral anticoagulation

  Research output: Contribution to journal › Editorial › peer-review

• Impact of edoxaban on haemostasis diagnosis assays: Practical recommendations

  Research output: Contribution to conference › Poster › peer-review

• Impact of edoxaban on haemostasis diagnosis assays: practical recommendations

  Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution

• Assessment of the impact of rivaroxaban on coagulation assays: Laboratory recommendations for the monitoring of rivaroxaban and review of the literature

  Research output: Contribution to journal › Article › peer-review

• Pourquoi, quand et comment doser les nouveaux anticoagulants oraux?

  Research output: Contribution to journal › Review article › peer-review

• Influence of dabigatran and rivaroxaban on routine coagulation assays: A nationwide Belgian survey

  Research output: Contribution to journal › Article › peer-review

• Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

  Research output: Contribution to journal › Article › peer-review

• Does the Russell Viper Venom time test provide a rapid estimation of the intensity of oral anticoagulation? A cohort study

  Research output: Contribution to journal › Article › peer-review

• Apixaban: Safety, usefulness and practical details of laboratory monitoring

  Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution

• Dabigatran Etexilate and Risk of Myocardial Infarction, Other Cardiovascular Events, Major Bleeding, and All-Cause Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials

  Research output: Contribution to journal › Article › peer-review

• Anticoagulants directs oraux: Actualités pour les biologistes

  Research output: Contribution to journal › Review article › peer-review

• Impact of edoxaban on a large panel of routine of more specific coagulation assays

  Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution

• Non-VKA oral anticoagulants: Accurate measurement of plasma drug concentrations

  Research output: Contribution to journal › Review article › peer-review

• Impact of apixaban on routine and specific coagulation assays: A practical laboratory guide

  Research output: Contribution to journal › Article › peer-review

• Estimation of dabigatran plasma concentrations in the preoperative setting: An ex vivo study using dedicated coagulation assays

  Research output: Contribution to journal › Article › peer-review

• Dose tailoring of dabigatran etexilate: Obvious or excessive?

  Research output: Contribution to journal › Article › peer-review

• Prizes

• Eberhard F. Mammen Young Investigator Award 2019

  Prize: National/international honour

• Projects

• Clinical Pharmacology Research Group

  Project: Research Axis

• The BIOCOAG project : Biological assessment of the control of anticoagulation

  Project: Research